These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current trends in blood component therapy: the evolution of a safer, more effective product. Baranowski L. J Intraven Nurs; 1992 Mar; 15(3):136-51. PubMed ID: 1608013 [Abstract] [Full Text] [Related]
3. Blood transfusion. Nerlich S. Aust Nurs J; 1998 Jun; 5(11):suppl i-iv. PubMed ID: 10639966 [Abstract] [Full Text] [Related]
4. [The Medical Products Agency should supervise blood production. Disagreement concerning men who had sexual contacts with men has brought matters to a head]. Söderström T. Lakartidningen; 1998 Jun; 108(39):1894. PubMed ID: 22111225 [No Abstract] [Full Text] [Related]
5. Administration of blood products. McMahon M. Int J Trauma Nurs; 2000 Jun; 6(3):95-100. PubMed ID: 10891848 [No Abstract] [Full Text] [Related]
6. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products. O'Mahony B, Turner A. Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632 [No Abstract] [Full Text] [Related]
7. The quality of blood products in Mississippi takes another leap forward. Jett PL. J Miss State Med Assoc; 1999 Nov; 40(11):390-1. PubMed ID: 10568090 [No Abstract] [Full Text] [Related]
8. [Labile blood products and their preparation]. Chabanel A, Folléa G. Rev Prat; 2001 Jun 30; 51(12):1306-10. PubMed ID: 11503503 [Abstract] [Full Text] [Related]
9. The six questions of pathogen reduction technology: an overview of current opinions. Solheim BG, Seghatchian J. Transfus Apher Sci; 2008 Aug 30; 39(1):51-7. PubMed ID: 18614401 [Abstract] [Full Text] [Related]
12. An overview of the rationale, process, and nursing implications of peripheral blood stem cell transplantation. Walker F, Roethke SK, Martin G. Cancer Nurs; 1994 Apr 30; 17(2):141-8. PubMed ID: 8019998 [Abstract] [Full Text] [Related]
13. [Safety of plasma products may be improved]. Wahlberg T. Lakartidningen; 1995 Dec 20; 92(51-52):4869-70. PubMed ID: 8544500 [No Abstract] [Full Text] [Related]
14. [Blood transfusion and monitoring. Blood products for transfusion. Indications]. Gaspard M. Soins; 1996 Apr 20; (605):18-9. PubMed ID: 8716243 [No Abstract] [Full Text] [Related]
15. [Do we have a good blood supply?]. Seitz R. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Oct 20; 56(10):1349-51. PubMed ID: 24162028 [No Abstract] [Full Text] [Related]
16. [Checking of blood product in hospital]. Girard A. Transfus Clin Biol; 2004 Oct 20; 11(4):205-9. PubMed ID: 15564102 [Abstract] [Full Text] [Related]
17. Red blood cells, plasma, and other new apheresis-derived blood products: improving product quality and donor utilization. Smith JW, Gilcher RO. Transfus Med Rev; 1999 Apr 20; 13(2):118-23. PubMed ID: 10218235 [No Abstract] [Full Text] [Related]
18. International forum on 'Perioperative blood salvage': a Spanish contribution. Muñoz M, Gómez-Luque A, Ramírez G, GIEMSA (Multidisciplinary Autotransfusión Study Group). Vox Sang; 2007 Jan 20; 92(1):90. PubMed ID: 17181596 [No Abstract] [Full Text] [Related]
19. The use of blood products in shock. Nacht A. Crit Care Clin; 1992 Apr 20; 8(2):255-91. PubMed ID: 1568140 [Abstract] [Full Text] [Related]
20. Making sense of the use of blood and blood products. Dodsworth H. Nurs Times; 1992 Apr 20; 91(1):25-7. PubMed ID: 7838744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]